Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
Authors
Keywords
Cancer stem cell, Drug resistance, Nanotechnology, Gene therapy, Immunotherapy, Review
Journal
TUMOR BIOLOGY
Volume 37, Issue 10, Pages 13059-13075
Publisher
Springer Nature
Online
2016-08-26
DOI
10.1007/s13277-016-5294-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway
- (2015) Hyunsook An et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery
- (2015) Jijin Gu et al. BIOMATERIALS
- DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
- (2015) Olga Grishina et al. BMC CANCER
- Nanobiotechnological Approaches to Overcome Drug Resistance in Breast Cancer
- (2015) Peyman Ranji et al. CURRENT CANCER DRUG TARGETS
- Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15
- (2015) Vita Golubovskaya et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts
- (2015) Yinan Zhong et al. JOURNAL OF CONTROLLED RELEASE
- Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells
- (2015) Mohammad Johari-Ahar et al. JOURNAL OF DRUG TARGETING
- Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
- (2015) Lei Zhao et al. JOURNAL OF IMMUNOTHERAPY
- Mitochondrial targeted peptides for cancer therapy
- (2015) Sadaf Farsinejad et al. TUMOR BIOLOGY
- Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model
- (2015) Cuiping Yang et al. Oncotarget
- The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma
- (2015) Andrea Di Cristofori et al. Oncotarget
- MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
- (2015) Xiaoqian Yang et al. Scientific Reports
- EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
- (2015) Tao Wang et al. Theranostics
- The Role of CD44 in Disease Pathophysiology and Targeted Treatment
- (2015) Andre R. Jordan et al. Frontiers in Immunology
- EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
- (2015) Nithya Subramanian et al. PLoS One
- Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status
- (2015) Zhiguang Xiao et al. Oncotarget
- Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features
- (2015) Elina Jokinen et al. Oncotarget
- Selective inhibition of breast cancer stem cells by gold nanorods mediated plasmonic hyperthermia
- (2014) Yingying Xu et al. BIOMATERIALS
- A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth
- (2014) Maria B Lebron et al. CANCER BIOLOGY & THERAPY
- Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling
- (2014) Neng Wang et al. CARCINOGENESIS
- Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
- (2014) Mohammad Hojjat-Farsangi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Folate and CD44 Receptors Dual-Targeting Hydrophobized Hyaluronic Acid Paclitaxel-Loaded Polymeric Micelles for Overcoming Multidrug Resistance and Improving Tumor Distribution
- (2014) Yanhua Liu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The novel EpCAM-targeting monoclonal antibody 3–17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines
- (2014) Kaja Lund et al. mAbs
- MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance
- (2014) Richard Ottman et al. Molecular Cancer
- Targeting MET for glioma therapy
- (2014) Ahmed J. Awad et al. Neurosurgical Focus
- Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation
- (2014) O Shimozato et al. ONCOGENE
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like Cells
- (2014) Prakash Rath et al. Translational Oncology
- Metastasis review: from bench to bedside
- (2014) Ali Mohammad Alizadeh et al. TUMOR BIOLOGY
- An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity
- (2014) U Krause et al. Cell Death & Disease
- EpCAM proteolysis: new fragments with distinct functions?
- (2013) Ulrike Schnell et al. BIOSCIENCE REPORTS
- The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents
- (2013) C. Dos Santos et al. BLOOD
- Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists
- (2013) Kenneth K W To et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy
- (2013) Manuel Simon et al. Expert Opinion on Drug Delivery
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- A new gamboge derivative Compound 2 inhibits cancer stem-like cellsviasuppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma
- (2013) Rongxin Deng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma
- (2013) H. Hou et al. MOLECULAR CANCER THERAPEUTICS
- Nanofiber-mediated inhibition of focal adhesion kinase sensitizes glioma stemlike cells to epidermal growth factor receptor inhibition
- (2013) Maya Srikanth et al. NEURO-ONCOLOGY
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Head and Neck Cancer Stem Cells to Overcome Resistance to Photon and Carbon Ion Radiation
- (2013) Gérald Bertrand et al. Stem Cell Reviews and Reports
- Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells—an in vitro and in silico study
- (2013) Santhi Latha Pandrangi et al. TUMOR BIOLOGY
- Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer
- (2012) Chi-Tai Yeh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
- (2012) Makoto Kubo et al. BREAST CANCER RESEARCH AND TREATMENT
- Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
- (2012) Y.-P. Liu et al. CANCER RESEARCH
- Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors
- (2012) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
- Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells
- (2012) Ji-Young Jang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
- (2012) Hans-Joachim Schmoll et al. JOURNAL OF CLINICAL ONCOLOGY
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- New Use for an Old Drug: Inhibiting ABCG2 with Sorafenib
- (2012) Y. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Cancer stem cells and drug resistance: the potential of nanomedicine
- (2012) Serguei Vinogradov et al. Nanomedicine
- Aptamers and Their Biological Applications
- (2012) Kyung-Mi Song et al. SENSORS
- Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches
- (2012) Cristóbal Aguilar-Gallardo et al. Stem Cell Reviews and Reports
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
- (2012) Xue Xue et al. Chinese Journal of Cancer
- Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery
- (2012) Timothy E. Andrews et al. Drug Delivery and Translational Research
- Cancer stem cells and therapeutic targets: an emerging field for cancer treatment
- (2012) Arokia Priyanka Vaz et al. Drug Delivery and Translational Research
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line
- (2011) Jun Dou et al. CELL BIOLOGY INTERNATIONAL
- Targeting the Multidrug ABCG2 Transporter with Flavonoidic Inhibitors: In Vitro Optimization and In Vivo Validation
- (2011) A. Boumendjel et al. CURRENT MEDICINAL CHEMISTRY
- Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
- (2011) Angela Alama et al. DRUG DISCOVERY TODAY
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells
- (2011) Celia Chao et al. LABORATORY INVESTIGATION
- Sustained Expression of the RON Receptor Tyrosine Kinase by Pancreatic Cancer Stem Cells as a Potential Targeting Moiety for Antibody-Directed Chemotherapeutics
- (2011) Snehal S. Padhye et al. MOLECULAR PHARMACEUTICS
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
- (2011) L Y W Bourguignon et al. ONCOGENE
- ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma
- (2011) R R Singh et al. ONCOGENE
- Inhibition of Ataxia Telangiectasia- and Rad3 -Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction
- (2011) Eike Gallmeier et al. STEM CELLS
- Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells
- (2010) Ji-Young Jang et al. BMC CANCER
- Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
- (2010) Markus Münz et al. Cancer Cell International
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- The cancer stem cell paradigm: a new understanding of tumor development and treatment
- (2010) Johnathan D Ebben et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells
- (2010) Tung-Ying Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sunitinib Malate and Figitumumab in Solitary Fibrous Tumor: Patterns and Molecular Bases of Tumor Response
- (2010) S. Stacchiotti et al. MOLECULAR CANCER THERAPEUTICS
- The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
- (2010) Irene Ma et al. Stem Cell Reviews and Reports
- A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
- (2009) Brian Thiessen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair
- (2009) E. Bolderson et al. CLINICAL CANCER RESEARCH
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
- (2009) Sung Pil Hong et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
- (2009) Alexei V. Salnikov et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-Cell lymphoma
- (2009) Ji Eun Kim et al. MODERN PATHOLOGY
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature
- (2009) William J. Black et al. Pharmacogenetics and Genomics
- A Novel Two Mode-Acting Inhibitor of ABCG2-Mediated Multidrug Transport and Resistance in Cancer Chemotherapy
- (2009) Hui Peng et al. PLoS One
- Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
- (2008) Satori A Marchitti et al. Expert Opinion on Drug Metabolism & Toxicology
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started